J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Spark, Pfizer's Gene Therapy Hemophilia B Drug Stuns in Trial December 6, 2017 Bay Area's XOMA Snags $240M Deal With Newly-Transformed Rezolute December 6, 2017 The Biggest Winners and Losers of JPM 2018 January 16, 2018
